Arevipharma – manufacturing health.
Your active ingredient partner from Germany.
Arevipharma is a modern manufacturer of active pharmaceutical ingredients and complex fine chemicals. Through our products, we contribute to the health of millions of people on every continent. We are manufacturing health!
At our Radebeul site, we manufacture cGMP active pharmaceutical ingredients in five production facilities, ranging in scale from a few grams to three-digit tons per year.
Thanks to our decades of expertise in the production, regulatory approval, and marketing of APIs, Arevipharma is a key partner and supplier to numerous small, medium, and large pharmaceutical customers around the world.
Arevipharma is a fully integrated manufacturer of active pharmaceutical ingredients. Our facility encompasses the full range of infrastructure and services expected of an API company: from product development, production, quality assurance and quality control, HSE, engineering, and process technology to regulatory affairs, logistics, and sales.
Providing the best customer service and ensuring the first-class quality of our active pharmaceutical ingredients (APIs) across all global pharmaceutical markets is the guiding principle of our business. With our APIs, we have always made a decisive contribution to health, and we never compromise on the high quality of our products.
In addition to quality, reliability as a supplier to our customers is our top priority in order to guarantee the continuity of the drug supply. In times of strained global supply chains, it is our mission as a German manufacturer within a network of key European partners to contribute to supply security in the pharmaceutical industry.
Narcotics
Arevipharma makes a significant contribution to patient care in pain management through the production of anesthetics.
Narcotic substances (BtM) as defined by the Narcotics Act (BtMG) are substances that, due to their mode of action, cause dependence and are therefore classified as such. The assessment also takes into account the direct risk to health posed by the misuse of the substance.
Arevipharma takes this responsibility very seriously and works closely with the Federal Opium Agency at the BfArM and other authorities worldwide.
Facts and Figures
We manufacture 40 active pharmaceutical ingredients for various therapeutic areas, such as pain management, the central nervous system, cardiovascular, and others.
DMF documentation for all our products is prepared in accordance with the latest EDQM (CEP), ICH (EuDMF, CTD) and FDA (US DMF) requirements.
At our facilities, we manufacture pharmaceutical products that require complex chemistry and technical expertise, always with the highest quality standards as our top priority.
Our employees help you achieve your goals and build on your company’s success, and we have long enjoyed a reputation as a competent business partner.
Your reliable partner
Our sites
At our Radebeul site, we manufacture active pharmaceutical ingredients in five production facilities on a scale ranging from a few grams to several hundred metric tons per year, in accordance with cGMP standards. Thanks to our decades of expertise in the manufacture, approval, and marketing of APIs, Arevipharma is a key partner and supplier to numerous small, medium, and large pharmaceutical customers around the world.
In addition to the Radebeul production facility, a sales office has been opened in the USA in 2021 to further expand business in this part of the world.
